Table 1.
Baseline Characteristics
| Variable | Value (n=102) |
|---|---|
| Demographic variable | |
| Age, yr | 64.3 (53.6–72.8) |
| Male sex | 83 (81.4) |
| Body mass index, kg/m2 | 23.9 (21.3–25.8) |
| Diabetes mellitus | 44 (43.1) |
| Hypertension | 59 (57.8) |
| Viral etiology | 71 (69.6) |
| Liver cirrhosis | 28 (27.5) |
| Laboratory variables | |
| Platelet count, ×109/L | 198.5 (121.3–261.5) |
| Total bilirubin, mg/dL | 0.6 (0.5–0.9) |
| Serum albumin, g/dL | 3.9 (3.5–4.1) |
| Aspartate aminotransferase, IU/L | 40.0 (28.8–64.3) |
| Alanine aminotransferase, IU/L | 28.5 (18.0–45.0) |
| Alkaline phosphatase, IU/L | 95.5 (76.0–138.5) |
| Prothrombin time, INR | 1.02 (0.96–1.10) |
| AFP, ng/mL | 37.1 (5.0–2,590.1) |
| >200 | 39 (38.2) |
| >400 | 36 (35.3) |
| DCP, mAU/mL | 1,780.0 (135.5–8,119.5) |
| >13,000 | 19 (18.6) |
| Tumor characteristics | |
| Nodular/infiltrative | 82 (80.4)/20 (19.6) |
| Maximum tumor size, cm | 8.3 (6.0–10.5) |
| Multiple tumors | 36 (35.3) |
| Above 3 tumors | 26 (25.5) |
| Tumor burden >50% | 10 (9.8) |
| Bilobar distribution | 28 (27.5) |
| Portal vein thrombosis | 19 (18.6) |
| Segmentary order branch | 5 (4.9) |
| Second order branch | 6 (5.9) |
| First order branch | 8 (7.8) |
| Hepatic vein invasion | 5 (4.9) |
Data are presented as median (interquartile range) or number (%).
INR, international normalized ratio; AFP, alpha-fetoprotein; DCP, des-gamma-carboxyprothrombin.